Zdrowie i gospodarka · 13/09/2004

FDA Releases Revised Draft Guidance on Delayed Ventricular Repolarization for Human Pharmaceuticals

The FDA has made available a revised draft guidance on nonclinical testing for delayed ventricular repolarization, a potential risk for certain pharmaceuticals, as part of the International Conference on Harmonisation's efforts to standardize pharmaceutical testing.